Table 1 Demographic and clinical characteristics of study participants

Age

33 (28, 39)

38(34,46)

46(39,48)

43(39,4)

37(32,42)

30 (27, 36)

Marital status

Married

456 (88%)

46 (82%)

18 (67%)

10 (83%)

89 (95%)

293 (89%)

Single

35 (6.8%)

1 (1.8%)

0 (0%)

1(8.3%)

3 (3.2%)

30 (9.1%)

Widow

26 (5.0%)

9 (16%)

9 (33%)

1(8.3%)

2 (2.1%)

5 (1.5%)

Parity

3.0(3.0,4.0)

4.0(3.0,4)

4.0(4.0,5)

4.0(3.0,5.0)

4.0(3.0,5)

3.0(3.0, 4.0)

Contraceptive’s type

Hormonal-IUD

29 (5.6%)

4 (7.1%)

3 (11%)

0 (0%)

2 (2.1%)

20 (6.1%)

Implant Jadele / Norplant

179 (35%)

24 (43%)

8 (30%)

3 (25%)

36 (38%)

108 (33%)

injectable /DepProvera

202 (39%)

18 (32%)

6 (22%)

5 (42%)

43 (46%)

130 (40%)

None

50 (9.7%)

9 (16%)

10 (37%)

3 (25%)

9 (9.6%)

19 (5.8%)

Oral pill

57 (11%)

1 (1.8%)

0 (0%)

1 (8.3%)

4 (4.3%)

51 (16%)

Duration (Yrs.)

11 (7, 15)

13(11,17)

13 (0, 17)

15 (8,18)

13(10, 19)

10 (7, 13)

VIA

negative

341 (66%)

35 (63%)

11(41%)

5 (42%)

58 (62%)

232 (71%)

positive

176 (34%)

21 (37%)

16(59%)

7 (58%)

36 (38%)

96 (29%)

HPV test

negative

107 (21%)

3 (5.4%)

2 (7.4%)

1 (8.3%)

12(12.8)

89 (27%)

positive

410 (79%)

53(94.6)

25(92.6)

11(91.7%)

82 (87%)

239 (73%)

HIV status

negative

394 (76%)

22 (39%)

12(44%)

6 (50%)

63 (67%)

291 (89%)

positive

123 (24%)

34 (61%)

15(56%)

6 (50%)

31 (33%)

37 (11%)

HSV-2

negative

471(91%)

40(71%)

23(85%)

9(75%)

83(88%)

316(96%)

positive

46(8.9%)

16(29%)

4(15%)

3(25%)

11(12%)

12(3.7%)

Chlamydia

Negative

454 (88%)

35 (63%)

20(74%)

8 (67%)

83 (88%)

308 (94%)

Positive

63 (12%)

21 (38%)

7 (26%)

4 (33%)

11 (12%)

20 (6.1%)